Literature DB >> 18410850

Discontinuation of medications after successful epilepsy surgery in children.

Deepak K Lachhwani1, Tobias Loddenkemper, Katherine D Holland, Prakash Kotagal, Edward Mascha, William Bingaman, Elaine Wyllie.   

Abstract

To evaluate the need for antiepileptic drugs after successful epilepsy surgery in pediatric patients, we retrospectively reviewed patients who had epilepsy surgery and were seizure free or had rare nondisabling auras during the first 6 postoperative months. Association between drug discontinuation and seizure recurrence was evaluated using Cox proportional hazards multivariable survival analysis. Medications were withdrawn in 68 of 97 patients, seizure free (or with rare nondisabling auras) for >6 months after surgery; 57 of the 68 (84%) remained seizure free; the other 11 (16%) had seizure recurrence after 68 months (median). Seizure recurrence was controlled with medication in 7 of the 11 patients (3 have rare seizures, 1 frequent auras). Discontinuing medications at <6 mo, compared with later or no withdrawal, had significant risk for seizure recurrence (hazard ratio 5.8; 95% confidence interval 1.8, 17.5; P = 0.003). Of 29 patients who continued drugs, 28 (97%) remained seizure free after 37 months (median). Freedom from seizures 6 months after surgery predicted good outcome (95% seizure free, with or without medication). If discontinuation is offered after 6 months, the majority of patients (84%) can be expected to remain seizure free with no further need for medication. Although seizure breakthrough is possible in a smaller percentage, restarting drugs is likely to restore seizure control.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18410850     DOI: 10.1016/j.pediatrneurol.2008.01.010

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  6 in total

1.  Medication management after epilepsy surgery: opinions versus facts.

Authors:  Lara Jehi
Journal:  Epilepsy Curr       Date:  2013-07       Impact factor: 7.500

2.  Does early postoperative drug regimen impact seizure control in patients undergoing temporal lobe resections?

Authors:  Barbara Schmeiser; Bernhard J Steinhoff; Andreas Schulze-Bonhage
Journal:  J Neurol       Date:  2018-01-06       Impact factor: 4.849

3.  Improved outcomes in pediatric epilepsy surgery: the UCLA experience, 1986-2008.

Authors:  M Hemb; T R Velasco; M S Parnes; J Y Wu; J T Lerner; J H Matsumoto; S Yudovin; W D Shields; R Sankar; N Salamon; H V Vinters; G W Mathern
Journal:  Neurology       Date:  2010-04-28       Impact factor: 9.910

4.  Uncertainties from a worldwide survey on antiepileptic drug withdrawal after seizure remission.

Authors:  Luca Bartolini; Shahram Majidi; Mohamad Z Koubeissi
Journal:  Neurol Clin Pract       Date:  2018-04

5.  Reducing versus stopping antiepileptic medications after temporal lobe surgery.

Authors:  Ruta Yardi; Anna Irwin; Husam Kayyali; Ajay Gupta; Dileep Nair; Jorge Gonzalez-Martinez; William Bingaman; Imad M Najm; Lara E Jehi
Journal:  Ann Clin Transl Neurol       Date:  2014-02-11       Impact factor: 4.511

6.  Epilepsy surgery for low-grade epilepsy-associated neuroepithelial tumor of temporal lobe: a single-institution experience of 61 patients.

Authors:  Zhe Zheng; Hongjie Jiang; Hemmings Wu; Yao Ding; Shuang Wang; Wenjie Ming; Junming Zhu
Journal:  Neurol Sci       Date:  2021-11-24       Impact factor: 3.830

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.